Xeris Biopharma CFO Steven Pieper sells 5,000 shares worth $42,500
XERS•CFO share sale disclosed
- Xeris Biopharma CFO Steven Pieper sold 5,000 common shares on Aug. 12, 2026 at $8.50 each.
- Direct holdings fell to 1,361,053 shares.
- The sale was executed under a Rule 10b5-1 trading plan adopted on Aug. 18, 2025.




